Skip Navigation

Cardiovascular Research 2000 47(3):475-488; doi:10.1016/S0008-6363(00)00118-8
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Corrigendum (v57,p869)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mezzetti, A.
Right arrow Articles by Cuccurullo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mezzetti, A.
Right arrow Articles by Cuccurullo, F.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm

Andrea Mezzetti*, Francesco Cipollone and Franco Cuccurullo

Department of Medicine and Aging, University of Chieti "G D’Annunzio" School of Medicine, Chieti, Italy

* Corresponding author. Centro per la Prevenzione dell’Aterosclerosi, la Diagnosi e Terapia dell’Ipertensione Arteriosa e delle Dislipidemie, Nuovo Policlinico SS. Annunziata, Via dei Vestini 66, 66013 Chieti, Italy. Tel.: +39-0871-3556-462; fax: +39-0871-3556-462 mezzetti{at}unich.it

Long-term vascular complications still represent the main cause of morbidity and mortality in diabetic patients. Although randomized long-term clinical studies comparing the effects of conventional and intensive therapy have demonstrated a clear link between hyperglycemia and the development of complications of diabetes, they have not defined the mechanism through which excess glucose results in tissue damage. Evidence has accumulated indicating that oxidative stress may play a key role in the etiology of diabetic complications. Isoprostanes are emerging as a new class of biologically active products of arachidonic acid metabolism of potential relevance to human vascular disease. Their formation in vivo seems to reflect primarily, if not exclusively, a nonenzymatic process of lipid peroxidation. Enhanced urinary excretion of 8-iso-PGF2{alpha} has been described in association with both type 1 and type 2 diabetes mellitus, and correlates with impaired glycemic control. Besides providing a likely noninvasive index of lipid peroxidation in this setting, measurements of specific F2 isoprostanes in urine may provide a sensitive biochemical end point for dose-finding studies of natural and synthetic inhibitors of lipid peroxidation. Although the biological effects of 8-iso-PGF2{alpha} in vitro suggest that it and other isoeicosanoids may modulate the functional consequences of lipid peroxidation in diabetes, evidence that this is likely in vivo remains inadequate at this time.

KEYWORDS Cholesterol; Coronary disease; Diabetes; Free radicals; Lipid metabolism


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article

Corrigendum to: "Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm": [Cardiovascular Research 47 (2000) 475–488]
Andrea Mezzetti, Francesco Cipollone, and Franco Cuccurullo
Cardiovasc Res 2003 57: 869. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
J. Y. Kim, Y. J. Hyun, Y. Jang, B. K. Lee, J. S. Chae, S. E. Kim, H. Y. Yeo, T.-S. Jeong, D. W. Jeon, and J. H. Lee
Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study
Am. J. Clinical Nutrition, September 1, 2008; 88(3): 630 - 637.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Nitenberg
Macrovascular disease in type 2 diabetes: We do need animal models for in vivo studies
Cardiovasc Res, February 1, 2007; 73(3): 450 - 452.
[Full Text] [PDF]


Home page
HypertensionHome page
Y. Ishikawa, T. Nishikimi, K. Akimoto, K. Ishimura, H. Ono, and H. Matsuoka
Long-Term Administration of Rho-Kinase Inhibitor Ameliorates Renal Damage in Malignant Hypertensive Rats
Hypertension, June 1, 2006; 47(6): 1075 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
R. Wolfram, A. Oguogho, B. Palumbo, and H. Sinzinger
Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi-PGF2{alpha}
Eur J Heart Fail, March 2, 2005; 7(2): 167 - 172.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Pagnin, G. Fadini, R. de Toni, A. Tiengo, L. Calo, and A. Avogaro
Diabetes Induces p66shc Gene Expression in Human Peripheral Blood Mononuclear Cells: Relationship to Oxidative Stress
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1130 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Srivastava, M. Spite, J. O. Trent, M. B. West, Y. Ahmed, and A. Bhatnagar
Aldose Reductase-catalyzed Reduction of Aldehyde Phospholipids
J. Biol. Chem., December 17, 2004; 279(51): 53395 - 53406.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Hansel, P. Giral, E. Nobecourt, S. Chantepie, E. Bruckert, M. J. Chapman, and A. Kontush
Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4963 - 4971.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Violi, L Loffredo, L Musella, and A Marcoccia
Should antioxidant status be considered in interventional trials with antioxidants?
Heart, June 1, 2004; 90(6): 598 - 602.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Bagi, A. Koller, and G. Kaley
PPAR{gamma} activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H742 - H748.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. POLIAKOV, M.-L. BRENNAN, J. MACPHERSON, R. ZHANG, W. SHA, L. NARINE, R. G. SALOMON, and S. L. HAZEN
Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo
FASEB J, December 1, 2003; 17(15): 2209 - 2220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Bagi, A. Koller, and G. Kaley
Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1404 - H1410.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Kuroki, K. Isshiki, and G. L. King
Oxidative Stress: The Lead or Supporting Actor in the Pathogenesis of Diabetic Complications
J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S216 - 220.
[Full Text] [PDF]


Home page
HeartHome page
F Cipollone, M Fazia, A Iezzi, B Pini, F Costantini, D De Cesare, L Paloscia, G Materazzo, E D'Annunzio, T Bucciarelli, et al.
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis
Heart, July 1, 2003; 89(7): 773 - 779.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Madore, N. Harvey, J. Parent, P. Chapdelaine, J. A. Arosh, and M. A. Fortier
An Aldose Reductase with 20alpha -Hydroxysteroid Dehydrogenase Activity Is Most Likely the Enzyme Responsible for the Production of Prostaglandin F2alpha in the Bovine Endometrium
J. Biol. Chem., March 21, 2003; 278(13): 11205 - 11212.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. Chiarelli, F. Cipollone, A. Mohn, M. Marini, A. Iezzi, M. Fazia, S. Tumini, D. De Cesare, M. Pomilio, S. D. Pierdomenico, et al.
Circulating Monocyte Chemoattractant Protein-1 and Early Development of Nephropathy in Type 1 Diabetes
Diabetes Care, October 1, 2002; 25(10): 1829 - 1834.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. Block, M. Dietrich, E. P. Norkus, J. D. Morrow, M. Hudes, B. Caan, and L. Packer
Factors Associated with Oxidative Stress in Human Populations
Am. J. Epidemiol., August 1, 2002; 156(3): 274 - 285.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. H. Eckel, M. Wassef, A. Chait, B. Sobel, E. Barrett, G. King, M. Lopes-Virella, J. Reusch, N. Ruderman, G. Steiner, et al.
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of Atherosclerosis in Diabetes
Circulation, May 7, 2002; 105 (18): e138 - e143.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Dietrich, G. Block, M. Hudes, J. D. Morrow, E. P. Norkus, M. G. Traber, C. E. Cross, and L. Packer
Antioxidant Supplementation Decreases Lipid Peroxidation Biomarker F2-isoprostanes in Plasma of Smokers
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 7 - 13.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
M. Y Abeywardena and R. J Head
Longchain n-3 polyunsaturated fatty acids and blood vessel function
Cardiovasc Res, December 1, 2001; 52(3): 361 - 371.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.